Sarah Cannon Research Institute at HealthONE — Denver, Colorado

Sarah Cannon Research Institute at HealthONE is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Clinical Trials Trust Score: 29/100 (FAILING). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute at HealthONE has participated in 88 clinical trials with 37 currently active.

Therapeutic areas: Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC).

Sponsors: Phanes Therapeutics, Biomea Fusion Inc., CytomX Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Denver

Browse all research sites in Colorado · View every site in Denver

• Cancer Centers of Colorado at Saint Joseph Hospital
• Centura Health Porter Adventist Hospital
• University of Colorado Denver Health Sciences
• The Childrens Hospital
• Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
• University of Colorado Denver /ID# 233676
• University of Colorado Cancer Center
• Project Safe, University of Colorado
• National Jewish Health, University of Colorado Denver
• Regents of the University of Colorado
• University of Colorado Cancer Center at UC Health Sciences Center
• Denver Health and Hospitals

Sponsor Feasibility Report

Trust Score: 29/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute at HealthONE?

Sarah Cannon Research Institute at HealthONE has a Crixeo Trust Score of 29/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute at HealthONE conducted?

Sarah Cannon Research Institute at HealthONE has 88 clinical trials on record, with 37 currently active. Their work covers Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC).

Is Sarah Cannon Research Institute at HealthONE accredited by Crixeo Clinical Trials?

Sarah Cannon Research Institute at HealthONE has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute at HealthONE?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.